{
 "@context" : "http://schema.org",
  "id" : "http://bio2rdf.org/drugbank:DB00078",
  "type" : "Drug",
  "alternateName" : "Ig gamma-2A chain C region, membrane-bound form",
  "description" : "Indium conjugated murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. Ibritumomab is produced in Chinese hamster ovary cells and is composed of two murine gamma 1 heavy chains of 445 amino acids each and two kappa light chains of 213 amino acids each.",
  "doseSchedule" : "Kit form with  route",
  "legalStatus" : "approved",
  "mechanismOfAction" : "The Fab segment of the antibody targets the CD20 epitope on B-cells, allowing the radioactive yttrium to destroy the cell via production of beta particles.",
  "name" : "Ibritumomab",
  "schema:sameAs" : "https://www.drugbank.ca/drugs/DB00078",
  "schema:url" : "https://www.drugbank.ca/drugs/DB00078"
}